NASDAQ:TECH Bio-Techne Q1 2027 Earnings Results & Report $72.80 -0.05 (-0.06%) As of 12:28 PM Eastern This is a fair market value price provided by Massive. Learn more. Bio-Techne met analyst earnings expectations and beat on revenue in its Q1 2027 results, released November 9, 2026. The company reported EPS of $0.44 versus the $0.44 consensus estimate, while revenue of $299.71 million topped the $292.60 million estimate by $7.11 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2027Report DateNovember 9, 2026TimeAfter Market ClosesConference Call DateNovember 6, 2026Conference Call4:00 PM ET Bio-Techne EPS ResultsActual EPS$0.44Consensus EPS $0.44Beat/MissMet ExpectationsOne Year Ago EPSN/AEPS Beat Rate4 of last 8 quartersBio-Techne Revenue ResultsActual Revenue$299.71 millionExpected Revenue$292.60 millionBeat/MissBeat by +$7.11 millionYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Bio-Techne Q1 2027 Earnings FAQ Did Bio-Techne beat earnings estimates for Q1 2027? Bio-Techne (NASDAQ:TECH) reported earnings of $0.44 per share for Q1 2027, matching the consensus estimate of $0.44. The report was announced on Monday, November 9, 2026. What was Bio-Techne's revenue for Q1 2027? Bio-Techne reported revenue of $299.71 million for Q1 2027, against a consensus estimate of $292.60 million. Bio-Techne Earnings HeadlinesWallace Weitz's Top Q3 2026 Move: Bio-Techne Corp at a -1.42% Portfolio ImpactNovember 12 at 3:14 PM | finance.yahoo.comGermany's Merck raises 2026 guidance for third timeNovember 12 at 9:35 AM | msn.comTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.November 13 at 1:00 AM | Base Camp Trading (Ad)Bio-Techne Q1 Profit DownNovember 9, 2026 | rttnews.comBio-Techne Corporation Reports Earnings Results for the First Quarter Ended September 30, 2026November 6, 2026 | marketscreener.comMBio-Techne's $0.08 dividend hinges on Merck KGaA deal timing (NASDAQ: TECH)November 6, 2026 | americanbankingnews.comSee More Bio-Techne Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bio-Techne? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bio-Techne and other key companies, straight to your email. Email Address About Bio-TechneBio-Techne (NASDAQ:TECH) is a life sciences company that develops and supplies products and services used in biological research, drug development, and clinical diagnostics. Its offerings include proteins, antibodies, immunoassays, and small molecules, as well as instruments and analytical tools for studying cells and biological processes. The company also provides technologies for protein analysis, molecular diagnostics, and spatial biology. Its portfolio includes products and services associated with brands such as R&D Systems, Tocris, ProteinSimple, and Advanced Cell Diagnostics. Founded in 1976, Bio-Techne serves pharmaceutical and biotechnology companies, academic and government research institutions, and clinical laboratories worldwide.View Bio-Techne ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco's Record $30 Dividend Shows Just How Strong Its Cash Machine IsThese 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went ShoppingGolden Dome’s $185 Billion Question: Who Actually Gets Paid?3 Pharmaceutical Stocks That Offer Safety and GrowthFirefly Aerospace Lights Up a High-Risk Space Opportunity Upcoming Earnings Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
